FORGOTTEN HISTORY: 17 - Caught on Camera

FDA decision could increase access to abortion pills across Alaska

A new federal rule change could make it easier for Alaskans to access medical abortions, especially in rural communities.

Tribune News Service · Jan 17, 2023

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

The Conversation · Jan 13, 2023

A new Alzheimer’s drug has been approved. What to know about lecanemab

A new drug that appears to slow early Alzheimer’s disease is coming to the market.

Tribune News Service · Jan 12, 2023

Walgreens confirms plans to sell abortion pills under new FDA rules

Walgreens expects to offer abortion pills after the Food and Drug Administration changed its rules for the drug.

Tribune News Service · Jan 5, 2023

Taiwan rejects tonnes of 'toxic' crabs from China

Taiwanese health officials have rejected a 6,400-kilogramme shipment of live crabs from mainland China, citing toxins in the popular seafood — the first time that island authorities have identified a food-security issue with the crabs in the past two years.

Bangkok Post · Jan 4, 2023

Abortion pills can be sold at US pharmacies, the Food and Drug Administration rules

Activists hail the move as ‘a step in the right direction’

The Independent UK · Jan 4, 2023

The FDA finalizes rule expanding the availability of abortion pills

The Food and Drug Administration on Tuesday finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.

WEKU · Jan 4, 2023

Probe: Alzheimer's drug approval 'rife with irregularities'

The Food and Drug Administration's contentious approval of a questionable Alzheimer's drug is taking another hit

The Independent UK · Dec 29, 2022

House report questions FDA’s approval of Alzheimer’s drug

WASHINGTON — A joint investigation released Thursday by House Democrats identified unusual collaboration between Food and Drug Administration officials and drugmaker Biogen, highlighting potential problems in the agency’s approval of the controversial Alzheimer’s drug Aduhelm.

Tribune News Service · Dec 29, 2022

FDA changes Plan B label to clarify 'morning-after' pill doesn't cause abortion

The agency in a memo Friday said the emergency contraception pills are not the same as abortion pills — which end a pregnancy — a fact that has long been understood in the medical community.

WEKU · Dec 24, 2022